Onco-Innovations Limited
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-07-10
Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010's API
News release - English.pdf
News 2026-06-30
News release - English.pdf
News 2026-06-30
News release - English.pdf
News 2026-06-26
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
News release - English.pdf
News 2026-06-23
Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
News release - English.pdf
Transactions 2026-06-19 Financing
Onco-Innovations Announces Non-Brokered LIFE Offering
News release - English.pdf
News 2026-06-19
Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development; Also Announces Appointment of Mr. Dave Antony as CFO
News release - English.pdf
Ownership 2026-06-18
Mohamed, Islam G. · 10 - Acquisition or disposition in the public market
Insider trading – 2026-06-18
1 insider · $0 net
News 2026-06-16
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
News release - English.pdf
Transactions 2026-06-15 Financing
Final short form prospectus – English.pdf
News 2026-06-10
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
News release - English.pdf
Ownership 2026-06-10
O'Shaughnessy, Thomas Gerald sold +$11k
Insider trading – 2026-06-10
1 insider · −$11k net
News 2026-06-05
Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
News release - English.pdf
News 2026-06-02
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program Also Announces Marketing Program
News release - English.pdf
News 2026-05-19
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
News release - English.pdf
News 2026-05-15
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
News release - English.pdf
News 2026-05-12
Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
News release - English.pdf
News 2026-05-08
Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
News release - English.pdf
Transactions 2026-05-05 Financing
Amendment to (or amended) preliminary short form prospectus – English.pdf
Transactions 2026-05-05 Financing
Other material contract(s).pdf
Transactions 2026-05-05 Financing
Other material contract(s).pdf
Results 2026-05-05
Interim MD&A - English.pdf
Results 2026-05-05
Interim financial statements/report (amended) - English.pdf
Results 2026-05-05
Annual MD&A (amended) - English.pdf
Results 2026-05-05
Audited annual financial statements (amended) - English.pdf
News 2026-05-05
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
News release - English.pdf
News 2026-05-01
Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
News release - English.pdf
News 2026-04-29
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
News release - English.pdf
Ownership 2026-04-24
O'Shaughnessy, Thomas Gerald sold +$28k
Insider trading – 2026-04-24
1 insider · −$28k net
News 2026-04-23
Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
News release - English.pdf
Ownership 2026-04-23
Heinzl, Richard sold +$25k
Insider trading – 2026-04-23
1 insider · −$25k net
News 2026-04-21
Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program
News release - English.pdf
News 2026-04-07
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
News release - English.pdf
News 2026-03-26
Amended & restated business acquisition report - English.pdf
News 2026-03-18
Report of exempt distribution (45-106F1).pdf
Results 2026-03-17 Financials
Interim MD&A - English.pdf
Results 2026-03-17 Financials
Interim financial statements/report – English.pdf
Transactions 2026-03-17 Financing
Onco-Innovations Announces Closing of Private Placement
Material change report - English.pdf
Transactions 2026-03-12 Financing
Onco-Innovations Announces Closing of Private Placement
News release - English.pdf
Transactions 2026-03-05 Financing
Onco-Innovations Announces Private Placement
News release - English.pdf
Transactions 2026-02-12 Financing
Onco-Innovations Announces Amendment to Private Placement Pricing
News release - English.pdf
Transactions 2026-02-05 Financing
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
News release - English.pdf
News 2026-02-04
Decision Document (Preliminary).pdf
Transactions 2026-02-03 Financing
Preliminary short form prospectus – English.pdf
News 2026-01-21
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
News release - English.pdf
Ownership 2026-01-16
Heinzl, Richard sold +$7k
Insider trading – 2026-01-16
1 insider · −$7k net
News 2026-01-15
Cover letter.pdf
News 2026-01-15
Notice.pdf
News 2026-01-15
Letter from former auditor.pdf
News 2026-01-15
Letter from successor auditor.pdf
Ownership 2026-01-14
Heinzl, Richard sold +$3k
Insider trading – 2026-01-14
1 insider · −$3k net
News 2025-12-19
NI 44-101 Notice of intent to qualify – English.pdf
Results 2025-12-15 Financials
Interim MD&A - English.pdf
Results 2025-12-15 Financials
Interim financial statements/report – English.pdf
News 2025-12-09
Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care
News release - English.pdf
News 2025-11-26
Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
News release - English.pdf
News 2025-11-21
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
News release - English.pdf
News 2025-11-18
Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
News release - English.pdf
News 2025-11-07
News release - English.pdf
Ownership 2025-11-07
Heinzl, Richard sold +$20k
Insider trading – 2025-11-07
1 insider · −$20k net
News 2025-11-01
Material change report - English.pdf
News 2025-11-01
Report of exempt distribution (45-106F1).pdf
News 2025-10-31
News release - English.pdf
News 2025-10-31
News release - English.pdf
News 2025-10-27
News release - English.pdf
News 2025-10-23
Material change report - English.pdf
News 2025-10-15
News release - English.pdf
News 2025-09-29
News release - English.pdf
News 2025-09-22
News release - English.pdf
Ownership 2025-09-22
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-09-22
1 insider · $0 net
News 2025-09-19
News release - English.pdf
News 2025-09-19
Statement of executive compensation (form 51-102F6V) - English.pdf
Ownership 2025-09-19
2 insiders · $0 net
Insider trading – 2025-09-19
2 insiders · $0 net
Ownership 2025-09-15
2 insiders · $0 net
Insider trading – 2025-09-15
2 insiders · $0 net
Results 2025-09-13 Financials
Interim MD&A - English.pdf
Results 2025-09-12 Financials
Interim financial statements/report – English.pdf
News 2025-09-12
News release - English.pdf
Ownership 2025-09-11
2 insiders · $0 net
Insider trading – 2025-09-11
2 insiders · $0 net
Ownership 2025-09-09
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-09-09
1 insider · $0 net
News 2025-09-05
News release - English.pdf
Ownership 2025-09-05
2 insiders · $0 net
Insider trading – 2025-09-05
2 insiders · $0 net
Ownership 2025-09-04
Bensler, Graydon · 10 - Acquisition or disposition in the public market
Insider trading – 2025-09-04
1 insider · $0 net
Ownership 2025-08-29
Bensler, Graydon · 10 - Acquisition or disposition in the public market
Insider trading – 2025-08-29
1 insider · $0 net
Ownership 2025-08-25
2 insiders · $0 net
Insider trading – 2025-08-25
2 insiders · $0 net
Ownership 2025-08-21
Bensler, Graydon · 10 - Acquisition or disposition in the public market
Insider trading – 2025-08-21
1 insider · $0 net
Ownership 2025-08-20
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-08-20
1 insider · $0 net
News 2025-08-16
Report of exempt distribution (45-106F1).pdf
News 2025-08-15
News release - English.pdf
Ownership 2025-08-15
2 insiders · $0 net
Insider trading – 2025-08-15
2 insiders · $0 net
Ownership 2025-08-14
Bensler, Graydon · 10 - Acquisition or disposition in the public market
Insider trading – 2025-08-14
1 insider · $0 net
News 2025-08-13
News release - English.pdf
Ownership 2025-08-11
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-08-11
1 insider · $0 net
News 2025-08-05
News release - English.pdf
Ownership 2025-08-05
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-08-05
1 insider · $0 net
Ownership 2025-08-01
Bensler, Graydon · 11 - Acquisition or disposition carried out privately
Insider trading – 2025-08-01
1 insider · $0 net
News 2025-07-30
News release - English.pdf
News 2025-07-30
News release - English.pdf
Results 2025-07-30 Financials
Annual information form - English.pdf
Results 2025-07-30 Financials
Annual MD&A - English.pdf
Results 2025-07-30 Financials
Audited annual financial statements – English.pdf
News 2025-07-22
Other.pdf
News 2025-07-21
News release - English.pdf
Ownership 2025-07-11
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-07-11
1 insider · $0 net
Ownership 2025-07-04
Stadnyk, Zachary Thomas · 10 - Acquisition or disposition in the public market
Insider trading – 2025-07-04
1 insider · $0 net
Ownership 2025-07-02
Bensler, Graydon · 10 - Acquisition or disposition in the public market
Insider trading – 2025-07-02
1 insider · $0 net
Ownership 2025-05-28
2 insiders · $0 net
Insider trading – 2025-05-28
2 insiders · $0 net
Ownership 2025-05-23
2 insiders · $0 net
Insider trading – 2025-05-23
2 insiders · $0 net
Ownership 2025-05-20
2 insiders · $0 net
Insider trading – 2025-05-20
2 insiders · $0 net